|
advertisement
|
|
|
| Journal Articles Details
|
| Pharmacogenomics Journals |
| Am J Transplant. 4(3):299-310 |
From pharmacokinetics to pharmacogenomics: a new approach to tailor immunosuppressive therapy. |
Cattaneo D, Perico N, Remuzzi G.
Department of Medicine and Transplantation, Ospedali Riuniti di Bergamo-Mario Negri Institute for Pharmacological Research, Bergamo, Italy. dcattaneo@marionegri.it |
Publication Date: Friday, February 13, 2004
|
Click here to view MEDLINE citation |
|
More February, 2004 pharmacogenomics journal articles.- The shift in the "paradigm" of the pharmacology of hypertension.
by Flordellis CS, Goumenos D, Kourounis G, Tsementzis SA, Paris H, Vlachojiannis J.
Journal: Curr Top Med Chem. 4(4):487-98
- The potential and limitations of personalised medicine in primary care.
by Hapgood R.
Journal: Br J Gen Pract. 53(497):915-6
- Bringing a dose of science to the art of medicine.
by
Journal: Nat Rev Drug Discov. 2(12):935
- Glucuronidation and the UDP-glucuronosyltransferases in health and disease.
by Wells PG, Mackenzie PI, Chowdhury JR, Guillemette C, Gregory PA, Ishii Y, Hansen AJ, Kessler FK, Kim PM, Chowdhury NR, Ritter JK.
Journal: Drug Metab Dispos. 32(3):281-90
- Will this drug work? Look to your genes.
by
Journal: Johns Hopkins Med Lett Health After 50. 16(1):3, 7
- The molecular pharmacology of organic anion transporters: from DNA to FDA?
by Eraly SA, Bush KT, Sampogna RV, Bhatnagar V, Nigam SK.
Journal: Mol Pharmacol. 65(3):479-87
- Global genetic analysis.
by Elahi E, Kumm J, Ronaghi M.
Journal: J Biochem Mol Biol. 37(1):11-27
- Pharmacogenetics of antihypertensive drug response.
by Kreutz R.
Journal: Curr Hypertens Rep. 6(1):15-20
- Study of resistance to anti-tuberculosis drugs in five districts of Equatorial Guinea: rates, risk factors, genotyping of gene mutations and molecular epidemiology.
by Tudó G, González J, Obama R, Rodríguez JM, Franco JR, Espasa M, Simarro PR, Escaramís G, Ascaso C, García A, Jiménez de Anta MT.
Journal: Int J Tuberc Lung Dis. 8(1):15-22
- Pharmacogenetic aspects of drug-induced torsade de pointes: potential tool for improving clinical drug development and prescribing.
by Shah RR.
Journal: Drug Saf. 27(3):145-72
- [Recent advances in pharmacogenomics in oncology]
by Robert J, Bonnet J.
Journal: Bull Cancer. 91(1):19-28
- Estimating predictors for long- or short-term survivors.
by Tian L, Wang W, Wei LJ.
Journal: Biometrics. 59(4):1008-15
- Incidence and distribution of argininosuccinate synthetase deficiency in human cancers: a method for identifying cancers sensitive to arginine deprivation.
by Dillon BJ, Prieto VG, Curley SA, Ensor CM, Holtsberg FW, Bomalaski JS, Clark MA.
Journal: Cancer. 100(4):826-33
- Pharmacogenetics, placebos and publication fraud.
by Mansell MA.
Journal: Med Leg J. 71(Pt 4):141-3
- Pharmacogenomics of psychiatric drug treatment.
by Mancama D, Arranz MJ, Kerwin RW.
Journal: Curr Opin Mol Ther. 5(6):642-9
- Toxicology investigations with cell culture systems: 20 years after.
by Zucco F, De Angelis I, Testai E, Stammati A.
Journal: Toxicol In Vitro. 18(2):153-63
- Pharmacogenetics and anticoagulant therapy.
by Gage BF, Eby CS.
Journal: J Thromb Thrombolysis. 2003 Aug-Oct;16(1-2):73-8
- Pharmacogenomic-guided rational therapeutic drug monitoring: conceptual framework and application platforms for atypical antipsychotics.
by Albers LJ, Ozdemir V.
Journal: Curr Med Chem. 11(3):297-312
- Genetics and drugs.
by
Journal: FDA Consum. 2004 Jan-Feb;38(1):7
More pharmacogenomics journal articles ... |
Journal Articles Categories:
Health Informatics Journal Articles |
Telemedicine Journal Articles |
Hospital Information Systems Journal Articles |
Data Protection and Privacy Journals Articles |
Mobile and Wireless Computing Journal Articles |
Medical Decision Making |
Bioinformatics Journal Articles |
Genomics Journal Articles |
Proteomics Journal Articles |
Pharmacogenomics Journal Articles
|